Jennifer Barr

Medicine · Health Sciences

30h-index2.9kcitations63works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virology and Viral Diseases(39), Viral Infections and Vectors(33), Rabies epidemiology and control(14), Vector-Borne Animal Diseases(12), SARS-CoV-2 and COVID-19 Research(11)

Publications63 total

Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024
Emerging infectious diseases·2026Open Access
Novel Henipavirus, Salt Gully Virus, Isolated from Pteropid Bats, Australia
Emerging infectious diseases·2025Open Access
Nipah virus vaccines evaluated in pigs as a ‘One Health’ approach to protect public health
npj Vaccines·2025Open Access
A nanobody-based therapeutic targeting Nipah virus limits viral escape
Nature Structural & Molecular Biology·2025· 3 cited
A protective bispecific antibody targets both Nipah virus surface glycoproteins and limits viral escape
2025· 1 citedOpen Access
Foals of mares vaccinated for Hendra virus have a suboptimal response to HeV vaccination
Veterinary Microbiology·2024· 2 citedOpen Access
Development and preliminary validation of a MERS-CoV ELISA for serological testing of camels and alpacas
Journal of Virological Methods·2024Open Access
Development and Validation of a Mers-Cov Elisa for Serological Testing of Camels and Alpacas
SSRN Electronic Journal·2024Open Access
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
Science Advances·2023· 12 citedOpen Access
A platform technology for generating subunit vaccines against diverse viral pathogens
Frontiers in Immunology·2022· 23 citedOpen Access
Detection of filovirus-reactive antibodies in Australian bat species
Journal of General Virology·2022· 8 citedOpen Access
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
Microorganisms·2022· 4 citedOpen Access
Characterisation and natural progression of SARS-CoV-2 infection in ferrets
Scientific Reports·2022· 25 citedOpen Access
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
npj Vaccines·2021· 58 citedOpen Access
<i>In vitro</i> characterisation of SARS‐CoV‐2 and susceptibility of domestic ferrets ( <i>Mustela putorius furo</i> )
Transboundary and Emerging Diseases·2021· 14 citedOpen Access
Type I Hypersensitivity in Ferrets Following Exposure to SARS-CoV-2 Inoculum: Lessons Learned
ILAR Journal·2021· 3 citedOpen Access
Spillover of bat borne Rubulavirus in Australian horses – Horses as sentinels for emerging infectious diseases
International Journal of Infectious Diseases·2020· 2 citedOpen Access
Spillover of bat borne rubulavirus in Australian horses – Horses as sentinels for emerging infectious diseases
International Journal of Infectious Diseases·2020Open Access
Achimota Pararubulavirus 3: A New Bat-Derived Paramyxovirus of the Genus Pararubulavirus
Viruses·2020· 14 citedOpen Access
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein
npj Vaccines·2020· 72 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Lin‐Fa Wang(31), Glenn A. Marsh(23), Gary Crameri(23), Shawn Todd(13), Meng Yu(12), Christopher C. Broder(12), Hume Field(10), James L. N. Wood(9), Andrew A. Cunningham(9), Ina Smith(9), Kate S. Baker(8), Mary Tachedjian(7), David T. S. Hayman(7), Peter A. Durr(7), Deborah Middleton(6), Adam J. Foord(6), Alison J. Peel(6), Gough G. Au(6), Victoria Boyd(6), Jean Payne(5)